Advanced liver fibrosis and the metabolic syndrome in a primary care setting,Diabetes/Metabolism Research and Reviews

当前位置： X-MOL 学术 › Diabetes Metab. Res. Rev. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Advanced liver fibrosis and the metabolic syndrome in a primary care setting
Diabetes/Metabolism Research and Reviews ( IF 4.6 ) Pub Date : 2021-03-23 , DOI: 10.1002/dmrr.3452
Andrew D Schreiner ₁ , Jingwen Zhang ₁ , Valerie Durkalski-Mauldin ₁ , Sherry Livingston ₁ , Justin Marsden ₁ , John Bian ₁ , Patrick D Mauldin ₁ , William P Moran ₁ , Don C Rockey ₁

Affiliation

The fibrosis-4 index (FIB-4) and NAFLD fibrosis score (NFS) are noninvasive and accessible methods for assessing advanced liver fibrosis risk in primary care. We evaluated the distribution of FIB-4 and NFS scores in primary care patients with clinical signals for nonalcoholic fatty liver disease (NAFLD).

中文翻译：